Isoniazid 300 Mg ORAL TABLET

DRUG3 trials

Sponsors

Instituto Nacional de Salud Publica, Mexico, University of California, San Francisco, Herlev and Gentofte Hospital

Conditions

Alcohol AbuseDiabetes MellitusDiabetes Mellitus, Type 2HIV/AIDSLatent TuberculosisTuberculin (Skin Test) PositiveTuberculosis

Phase 4

Efficacy, Security, Adherence, Tolerability and Cost Effectiveness of Latent TB Treatment in Patients With TB/DM2 (TBL)

CompletedNCT03278483

Instituto Nacional de Salud Publica, MexicoDiabetes Mellitus, Tuberculin (Skin Test) Positive

Start: 2019-02-28End: 2019-02-28Updated: 2019-04-26

Alcohol Drinkers' Exposure to Preventive Therapy for TB (ADEPTT)

CompletedNCT03302299

University of California, San FranciscoAlcohol Abuse, HIV/AIDS, Tuberculosis

Start: 2017-04-07End: 2021-04-01Updated: 2023-10-19

Impact of LTBI Treatment on Glucose Tolerance and Chronic Inflammation

CompletedNCT04830462

Herlev and Gentofte HospitalDiabetes Mellitus, Type 2, Latent Tuberculosis

Start: 2021-04-15End: 2023-05-01Updated: 2023-05-16

Related Papers

Association Between Alcohol Use, CD4 Count, and Depressive Symptoms Among People with HIV with Viral Load Suppressed in Southwestern Uganda.

2026-07-21

The impact of an oral glucose load on IFN-γ-release in persons infected with Mycobacterium tuberculosis.

2024-09-30

The effect of Mycobacterium tuberculosis treatment on thrombelastography-assessed haemostasis: a prospective cohort study.

2024-06-26